Nuwellis, Inc. (NUWE) vs Onconetix, Inc. (ONCO)
A side-by-side comparison of Nuwellis, Inc. and Onconetix, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NUWE
Nuwellis, Inc.
$0.72HealthcareDelayed quote: Oct 6, 2026, 2:48 PM EDT
ONCO
Onconetix, Inc.
$0.68HealthcareDelayed quote: Oct 6, 2026, 2:49 PM EDT
Total return — NUWE vs ONCO
growth of $100 · dividends reinvested · last 2yNUWE -97.8% (-85.3%/yr)ONCO -99.2% (-91.2%/yr)NUWE compounded faster over this window
NUWE ONCO
NUWE vs ONCO: by the numbers
- •NUWE is the larger company ($3M vs $2M market cap).
- •Both run net losses; NUWE's is the smaller (-123.38% vs -1578.79% net margin).
Metrics side by side
Valuation
| Metric | NUWE | ONCO |
|---|---|---|
| P/S ratio | 0.29 | 3.78 |
| P/B ratio | N/A | 0.18 |
Profitability
| Metric | NUWE | ONCO |
|---|---|---|
| Gross margin | 69.69% | 80.40% |
| Operating margin | -140.62% | -778.16% |
| Net margin | -123.38% | -1578.79% |
| ROE | N/A | -75.70% |
| ROIC | -238.32% | -59.84% |
Growth (annualized)
| Metric | NUWE | ONCO |
|---|---|---|
| Revenue CAGR (5Y) | 1.48% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.